Dr. Mitchell H. Sokoloff spoke at the 23rd annual Perspectives in Urology Point • Counterpoint meeting on Saturday, November 15, 2014 on “Systemic Therapies for Renal Cell Carcinoma.”
Keywords: renal cell carcinoma (RCC), systemic therapies, nephrectomy, metastasectomy, immunotherapy, targeted agents, mTOR inhibitors, PD-1 inhibitors, adjuvant therapy
How to cite: Sokoloff, Mitchell H. “Systemic Therapies for Renal Cell Carcinoma” Grand Rounds in Urology. July 1, 2015. Accessed Nov 2024. https://dev.grandroundsinurology.com/renal-cancer-mitchell-h-sokoloff-systemic-therapies/.
ABOUT THE AUTHOR
Mitchell H. Sokoloff, MD, FACS, is a Professor of Urology and Founding Chair of the Department of Urology at UMass Memorial Health Care and UMass Medical School in Worcester, Massachusetts. Dr. Sokoloff is board-certified in urology, with clinical specialties in the treatment of prostate, kidney, and testis cancer. His expertise includes robotic prostatectomy, nerve-sparing prostatectomy, nephron-sparing partial nephrectomy, and retroperitoneal lymph node dissection. He has particular expertise in the management of high-risk, locally-advanced and recurrent prostate, kidney, and testis cancer. He has received national peer-reviewed funding for basic and translational research. Dr. Sokoloff came to Worcester in March 2014 from his position as Professor of Surgery and Chief of the Urology Division of the Department of Surgery at the University of Arizona College of Medicine in Tucson, a position he had held since 2008. He earned his undergraduate and medical degrees from Stanford University in Palo Alto, California, and completed a residency in urology at UCLA School of Medicine in Los Angeles, as well as a fellowship in molecular urology and therapeutics at the University of Virginia in Charlottesville. At the University of Arizona, Dr. Sokoloff developed a nationally recognized program in genitourinary oncology that incorporated novel anti-cancer agents and technologies as a complement to conventional surgical therapy. Previously, Dr. Sokoloff was Chief of Urologic Oncology in the Division of Urology and Renal Transplantation and Director of Robotic Surgery in the Department of Surgery at Oregon Health and Science University in Portland, Oregon. Prior to that, he was Director of Urologic Oncology in the Division of Urology at the University of Chicago. He is a member of the American Association of Cancer Research, the American Urological Association, the American College of Surgeons, the Society for Urologic Oncology, the Society of Urologic Chairs and Program Directors, and the Society for Basic Urologic Research. He is the author or co-author of more than forty peer-reviewed publications and numerous book chapters and abstracts, and he has presented at a wide range of regional, national, and international meetings.